Results 41 to 50 of about 69,395 (344)

Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey

Harm Reduction Journal, 2020
Background In Belgium, people who inject drugs (PWID) are at a high risk of being infected by hepatitis C (HCV) as injecting drug use is the main mode for transmission of HCV in Europe.
Luk Van Baelen, Els Plettinckx, Jérôme Antoine, Lies Gremeaux   +3 more
doaj   +1 more source

A single site study to investigate the current prevalence of anti‐hepatitis C virus antibody among substance use disorder patients in Hiroshima—Insufficient testing and diagnosis

Neuropsychopharmacology Reports, 2023
Aims Hepatitis C virus (HCV) infection among drug users presents an important public health problem; however, little recognition and few approaches to address this issue in Japan.
Ariyuki Kagaya, Yuko Nagaoki, Satomi Shimura, Katsuyoshi Kawana, Kazuaki Chayama   +4 more
doaj   +1 more source

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study

Harm Reduction Journal, 2018
Background Despite increasing contraceptive availability, unintended pregnancy remains a global problem. Developing strategies to reverse this trend and increasing occurrence of withdrawal syndrome among newborn children of females currently injecting ...
Anneli Uusküla, Mait Raag, Sigrid Vorobjov, Don Des Jarlais   +3 more
doaj   +1 more source

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery

Harm Reduction Journal, 2023
Background The World Health Organization (WHO) recommends oral pre-exposure prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention.
Graham Shaw, Robin Schaefer, Heather-Marie A Schmidt, Annie Madden, Judy Chang, Antons Mozalevskis, Busisiwe Msimanga-Radebe, Nabeel Mangadan Konath, Annette Verster, Rachel Baggaley, Michelle Rodolph, Virginia Macdonald   +11 more
doaj   +1 more source

Young people who inject drugs in Mozambique: should we emphasize them in the National Harm Reduction Plan?

Harm Reduction Journal, 2020
Mozambique has one of the highest burdens of HIV globally, and people who inject drugs (PWID) have one of the highest HIV infection rates in Africa.
Cynthia Semá Baltazar, Makini Boothe, Timothy Kellogg   +2 more
doaj   +1 more source

Uptake of COVID-19 vaccination among people who inject drugs

Harm Reduction Journal, 2022
Background People who inject drugs (PWID) may be at elevated risk of adverse outcomes from SARS-CoV-2 infection; however, data on COVID-19 vaccine uptake among PWID are scarce.
Jenny Iversen, Handan Wand, Robert Kemp, Jude Bevan, Myf Briggs, Kate Patten, Sue Heard, Lisa Maher   +7 more
doaj   +1 more source

Hepatitis C virus risk among young people who inject drugs

Frontiers in Public Health, 2022
BackgroundInjection drug use (IDU) is the leading risk factor for hepatitis C virus (HCV) transmission in the U.S. While the general risk factors for HCV transmission are known, there is limited work on how these factors interact and impact young people ...
Pedro Mateu-Gelabert, Nasim S. Sabounchi, Honoria Guarino, Courtney Ciervo, Kellie Joseph, Benjamin J. Eckhardt, Chunki Fong, Shashi N. Kapadia, Terry T. K. Huang   +8 more
doaj   +1 more source

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs [PDF]

Clinical Infectious Diseases, 2013
Boceprevir and telaprevir are inhibitors and substrates of the cytochrome P450 3A4 family. With the use of these HCV protease inhibitors as part of standard therapy for chronic hepatitis C genotype 1 infection, drug-drug interactions with multiple medications being inductors, inhibitors, or substrates of cytochrome P450 3A4 can be expected.
Hartwig Klinker, Stefan Mauss
openaire   +3 more sources

Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis

BMC Infectious Diseases, 2019
Background In recent years, the number of infective endocarditis (IE) cases associated with injection drug use has increased. Clinical guidelines suggest deferring surgery for IE in people who inject drugs (PWID) due to a concern for worse outcomes in ...
David Goodman-Meza, Robert E. Weiss, Sebastián Gamboa, Abel Gallegos, Alex A. T. Bui, Matthew B. Goetz, Steven Shoptaw, Raphael J. Landovitz   +7 more
doaj   +1 more source

A pragmatic harm reduction approach to manage a large outbreak of wound botulism in people who inject drugs, Scotland 2015 [PDF]

, 2018
Background People who inject drugs (PWID) are at an increased risk of wound botulism, a potentially fatal acute paralytic illness. During the first 6 months of 2015, a large outbreak of wound botulism was confirmed among PWID in Scotland, which resulted ...
Amanda Weir, Andrew McAuley, CC McGuigan, CN Ramsay, Corinne Amar, D Akbulut, DJ Passaro, E MacDonald, E Tweed, European Centre for Disease Prevention and Control, Gauri Godbole, Gillian Penrice, GY Chang, Health Protection Scotland, Information Services Division (ISD), J McLauchlin, J Sobel, J Strang, JA Jones, JA Stoltz, K Alpers, K Dunleavy, Kathie Grant, Kirsten M. A. Trayner, Kirsty Roy, M Desai, M Harris, M Ragonnet-Cronin, M Schroeter, MG Booth, N Markwick, National Records of Scotland, NE Palmateer, Public Health England, Health Protection Scotland, Public Health Wales, and Public Health Agency Northern Ireland, RJ Gordon, SB Werner, Scottish Government, Scottish Health Protection Network, SJ Hahné, SR Offerman, TN Wenham, VD Hope, VD Hope, Y Soukup-Baljak   +43 more
core   +1 more source